Search

Introduction: The efficacy and safety of ainuovirine+lamivudine+tenofovir (ANV+3TC+TDF) and efavirenz+lamivudine+tenofovir (EFV+3TC+TDF) have been confirmed in previous clinical trials; however, there are no related studies on patient‐reported outcomes. This study aimed to evaluate the effectiveness and safety of these 2 antiretroviral therapy regimens and to understand the patient's symptom experience and subjective experience of sleep quality through patient‐reported outcomes. Methods: This is a single‐center prospective cohort study with 243 patients evaluated from October 1, 2021 to June 30, 2022. Virological effectiveness and patient‐reported outcomes results were analyzed. The primary endpoint was the proportion of HIV viral load <50 copies/mL (virological suppression rate) at 48 weeks and the changes in the HIV symptom index and Pittsburgh sleep quality index. Results: The virological suppression rates in the ANV+3TC+TDF and EFV+3TC+TDF groups were 83.6% (102/122) and 87.6% (106/121), respectively, at 48 weeks. In the ANV+3TC+TDF group, the scores of HIV symptom index and pittsburgh sleep quality index in the 48th week were lower than the baseline level (p < 0.05). Logistic regression results showed that the baseline regimen EFV+3TC+TDF was a risk factor for dizziness/lightheadedness (odds ratio = 3.153, 95% confidence interval: 1.473–6.748, p = 0.003), sadness/depression odds ratio = 2.404, 95% confidence interval:1.188–4.871, p = 0.015), and difficulty sleeping (odds ratio = 2.802, 95% confidence interval: 1.437–5.463, p = 0.002) at 48 weeks. Conclusions: Both regimens showed good virological effectiveness; however, compared with ANV+3TC+TDF, the EFV+3TC+TDF regimen reduced the prevalence of HIV‐related symptoms. [ABSTRACT FROM AUTHOR]

Background: Prospective studies examining long‐term therapeutic outcomes of the Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) regimen in human immunodeficiency virus (HIV) infection remain limited. This study assessed the actual efficacy and safety of BIC/FTC/TAF in HIV‐infected individuals in southwest China. Methods: This was a single‐center, prospective study enrolling ART‐naïve (n = 32) and ART‐experienced (n = 177) HIV‐infected patients administered BIC/FTC/TAF treatment between March 2022 and August 2022. The data were collected until February 28, 2023. Virological reactions and adverse events to the treatment were recorded, and patient subjective feelings in the form of Electronic Patient Reporting Outcome (ePRO) were collected. The primary endpoint was the rate of patients with HIV viral load <50 copies/mL at Week 24. Results: At Week 24, 87.5% and 95.5% of ART‐naïve and ART‐experienced HIV patients had a viral load <50 copies/mL, respectively. CD4 cell counts in ART‐naïve and ART‐experienced patients increased significantly by 163.5 cells/μL (p =.002) and 55.0 cells/μL (p =.022), respectively. By Week 24, no patients had discontinued the BIC/FTC/TAF treatment due to adverse events. Based on ePRO data, ART‐naïve and ART‐experienced patients at Week 24 had stable disease symptom burden, quality of life, and depression level after treatment with BIC/FTC/TAF. Conclusion: BIC/FTC/TAF reduces the viral load in ART‐naïve patients with high viral load as well as ART‐experienced patients with residual viremia. The patient's subjective experience was maintained stable after treatment with BIC/FTC/TAF. This study also revealed a very low incidence for BIC/FTC/TAF drug‐related side effects. [ABSTRACT FROM AUTHOR]

Loxoprofen sodium is a chiral drug with two chiral centers. In our previous work, we found that the elimination of its four isomers showed stereospecificity in rats, while how the stereospecific behavior occurred in vivo was unclear. To clarify this issue, each single isomer of loxoprofen sodium was prepared by a chiral semi‐preparative high‐performance liquid chromatography (HPLC) and then administered to rats. By analysis of each isomer in rat plasma utilizing an analytical chiral HPLC, it was discovered that the chiral inversion occurred only to its (2R)‐isomers, one from (1′S,2R)‐ to (1′S,2S)‐isomer and the other from (1′R,2R)‐ to (1′R,2S)‐isomer. The reduction of α‐substituted cyclopentanone occurred only to its (1′R)‐isomers, with (1′R,2R)‐isomer reduced to (2′S,1′R,2R)‐trans‐alcohol and (1′R,2S)‐ to (2′S,1′R,2S)‐trans‐alcohol. Interestingly, both the inversion and the reduction reaction occurred to its (1′R,2R)‐isomer due to the special stereo‐structure with both (2R)‐ and (1′R)‐configuration, and conversely, neither of them occurred to its (1′S,2S)‐isomer, which caused the significantly different elimination rate in vivo. These new findings were meaningful for evaluation of the safety and efficacy of chiral drugs. [ABSTRACT FROM AUTHOR]

A very broad acidity scale (≈40 pK units) for about 400 N‐heterocyclic carbene precursors (NHCPs) with various backbones and electronic features, including imidazolylidenes, 1,2,4‐triazolylidenes, cyclic diaminocarbenes (CDACs), diamidocarbenes (DACs), thiazolylidenes, cyclic (alkyl)(amino)carbenes (CAACs) and mesoionic carbenes (MICs), was established in DMSO by a well examined computational method. Varying the backbone structure or flanking N‐substituents can have different extent of acidifying effects, depending on both the nature and number of substituent(s). The Gibbs energies (ΔGrs) for the reactions between the corresponding NHCs and CO2 were also calculated. There is a good linear correlation between the pKas of most NHCPs and ΔGrs, suggesting that a greater basicity of NHC leads to a more stable NHC‐CO2 adduct. Interestingly, the nearby asymmetric environment has virtually no differential effect on the acidities of the chiral NHCP enantiomers, but has a pronounced effect on the ΔGr values. [ABSTRACT FROM AUTHOR]

Summary: Smart city can integrate cloud computing, big data, Internet of Things, edge computing, and other modern information technologies, which focuses on integration, sharing, utilization, and service of information resources, and emphasizes the cooperation and coordination of urban management, to achieve deep integration of industrialization and informatization. Data center network planning based on big data is involved in rational deployment and interconnection of network infrastructures, which can improve the network survivability, energy‐efficiency, flexibility, etc. Therefore, a survivable network planning model based on software‐defined networking is presented in this paper. The elastic network planning problem is formulated as a mixed‐integer optimization whose objective is to minimize the number of unprotected nodes. Then, 3 effective schemes including K‐means clustering algorithm based on simulated annealing, greedy routing algorithm, and Lagrangian relaxation algorithm are proposed for feasible solutions. Numerical results on practical network topology reveals that (1) K‐means clustering algorithm based on simulated annealing can make effective classification of different scale topologies; (2) compared with the traditional random deployment method, the greedy routing algorithm and Lagrangian relaxation algorithm can generate the controller deployment strategy more reasonably, and thus improve network survivability and deployment cost‐benefit. We present a survivable network planning model based on SDNThe elastic network planning problem is formulated as a mixed ILP problem to minimize the number of unprotected nodesThree effective schemes including K‐means clustering algorithm based on simulated annealing, greedy routing algorithm, and Lagrangian relaxation algorithm are proposed for feasible solutions. [ABSTRACT FROM AUTHOR]